Literature DB >> 8710757

The binding of cyclosporin A to human plasma: an in vitro microdialysis study.

H Yang1, W F Elmquist.   

Abstract

PURPOSE: The human plasma binding of cyclosporin A was studied in vitro using the technique of microdialysis. The effect of temperature on the overall binding interaction between cyclosporin A and human plasma was also investigated.
METHODS: Flow-through loop-type microdialysis probes were constructed from fused silica tubing and regenerated cellulose tubing with a MWCO of 13000 daltons. Probes were perfused with phosphate buffer (0.5 microliters/min) and the concentration of 3H-cyclosporin A in the well-mixed medium (plasma or buffer) was 1200 ng/ml. Relative recoveries of cyclosporin A from plasma or buffer were determined for each probe by separate experiments to measure the solute gain or loss with reference to the perfusate.
RESULTS: Recoveries determined by loss were significantly greater than those determined by gain and in each case temperature dependent, with higher recoveries at higher temperatures. The plasma free fraction of cyclosporin A calculated from the recovery data and the perfusate to plasma concentration ratios was dependent on temperature in a log-linear fashion. Mean +/- s.d. plasma free fractions expressed in percent were 33.5 +/- 4.6, 17.9 +/- 3.6, 6.2 +/- 0.8, 3.0 +/- 0.6, and 1.5 +/- 0.2 at temperatures of 4, 10, 20, 30, and 37 degrees C, respectively. Assuming that the enthalpy of binding is constant over the temperature range studied and pseudo-first order conditions exist, the binding reaction at these temperatures was spontaneous, endothermic (delta H = 74.0 kJ/mole), and entropically driven (delta S = 0.274 kJ/mole/deg).
CONCLUSIONS: These results show that the free fraction of cyclosporin A in human plasma is dependent on temperature with the fraction unbound decreasing with temperature in the range of 4 to 37 degrees C. The thermodynamic parameters for the binding of cyclosporin A to plasma components indicate that the reaction is a spontaneous endothermic reaction that is mainly entropy driven, similar to the partitioning of lipophilic molecules from an aqueous to a hydrophobic phase. Moreover, these results show that microdialysis is a feasible method to determine the binding interactions between plasma and cyclosporin A, which indicates the method may be suitable for other difficult binding studies where the solutes have nonspecific binding to separation devices.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8710757     DOI: 10.1023/a:1016066609489

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood.

Authors:  M Lemaire; J P Tillement
Journal:  J Pharm Pharmacol       Date:  1982-11       Impact factor: 3.765

2.  Nephrotoxicity of cyclosporin A in bone-marrow transplantation.

Authors:  E Gluckman; A Devergie; F Lokiec; O Poirier; A Baumelou
Journal:  Lancet       Date:  1981-07-18       Impact factor: 79.321

3.  A new method for measuring the free fraction of cyclosporin in plasma by equilibrium dialysis.

Authors:  S Henricsson
Journal:  J Pharm Pharmacol       Date:  1987-05       Impact factor: 3.765

4.  The pharmacokinetics of cyclosporine. II. Blood plasma distribution and binding studies.

Authors:  W M Awni; R J Sawchuk
Journal:  Drug Metab Dispos       Date:  1985 Mar-Apr       Impact factor: 3.922

5.  Intra- and interindividual variability in the free fraction of cyclosporine in plasma in recipients of renal transplants.

Authors:  A Lindholm; S Henricsson
Journal:  Ther Drug Monit       Date:  1989-11       Impact factor: 3.681

6.  Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation.

Authors:  K Atkinson; J Biggs; P Darveniza; J Boland; A Concannon; A Dodds
Journal:  Transplantation       Date:  1984-07       Impact factor: 4.939

7.  Cyclosporin: erythrocyte binding and an examination of its use to estimate unbound concentration.

Authors:  B Legg; M Rowland
Journal:  Ther Drug Monit       Date:  1988       Impact factor: 3.681

8.  The estimation of the plasma free fraction of cyclosporine in rabbits and heart transplant patients: the application of a physiological model of renal clearance.

Authors:  A K Shah; R C Brundage; K D Lake; R J Sawchuk
Journal:  Biopharm Drug Dispos       Date:  1995-01       Impact factor: 1.627

Review 9.  Microdialysis--principles and applications for studies in animals and man.

Authors:  U Ungerstedt
Journal:  J Intern Med       Date:  1991-10       Impact factor: 8.989

10.  Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury.

Authors:  H Shulman; G Striker; H J Deeg; M Kennedy; R Storb; E D Thomas
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245

View more
  6 in total

Review 1.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

Review 2.  Pharmacokinetic and metabolism studies using microdialysis sampling.

Authors:  D K Hansen; M I Davies; S M Lunte; C E Lunte
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

Review 3.  Molecular aspects of cyclophilins mediating therapeutic actions of their ligands.

Authors:  Andrzej Galat; Jacqueline Bua
Journal:  Cell Mol Life Sci       Date:  2010-07-04       Impact factor: 9.261

Review 4.  Distribution of cyclosporin in organ transplant recipients.

Authors:  Fatemeh Akhlaghi; Andrew K Trull
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Quantification of [(11)C]yohimbine binding to α2 adrenoceptors in rat brain in vivo.

Authors:  Jenny-Ann Phan; Anne M Landau; Dean F Wong; Steen Jakobsen; Adjmal Nahimi; Doris J Doudet; Albert Gjedde
Journal:  J Cereb Blood Flow Metab       Date:  2015-01-07       Impact factor: 6.200

6.  Zebrafish (Danio rerio) larva as an in vivo vertebrate model to study renal function.

Authors:  Jan Stephan Bolten; Anna Pratsinis; Claudio Luca Alter; Gert Fricker; Jörg Huwyler
Journal:  Am J Physiol Renal Physiol       Date:  2022-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.